Air Voel is shining a spotlight on the latest generation of sleep apnea therapy with the AirSense 11 CPAP machines, a solution that is quickly becoming the gold standard for Canadians seeking smarter, ...

ResMed maintains a five-year outlook of high single-digit revenue growth with earnings growth expected to consistently ...

Resmed Inc. RMD is well poised to grow in the coming quarters, driven by its sharpened focus on growing its core sleep apnea franchise, expanding into other adjacencies and investing in the digital ...

ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...

Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion of its nationwide distribution network for the highly in-demand ResMed AirSense ...

CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...